Data

Mobility insights for a better digital government

The Government Digital Service (GDS) has published a new report exploring Population Movement Data (PMD).

Backup and Disaster Recovery: Common encountered issues

Jeremy Wyatt, Operations Director at Fantastic Cloud Services Limited, explores some of the most commonly encountered issues organisations face when it comes to Backup and Disaster Recovery.

IMPAQT: Supporting the sustainable development of aquaculture

Here, Coordinator of the Intelligent Management Systems for Integrated Multi-Trophic Aquaculture (IMPAQT) project Frank Kane discusses the path to revolutionising aquaculture and increasing the industry’s sustainability.

How do you manage and control disparate data?

Here, Brendan Tate takes us on a journey through the reasons why he founded new start-up Cleata Limited, available on the G-Cloud framework.

Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three

The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.

COVID vaccines for mutations will be given faster approval in the UK

Medical regulators will fast-track COVID vaccines for mutations, similar to how seasonal flu shots are developed and released.

Tackling vaccination misinformation with local government communications

Karen Steel at Granicus discusses how local government communications could significantly help to stop the spread of COVID misinformation, especially when it comes to vaccinations.

Are swollen lymph nodes normal after getting the COVID vaccine?

According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".

Artificial Intelligence examines COVID misinformation on social media

A Northwestern Medicine study used Artificial Intelligence to analyse tweets and figure out how COVID misinformation on social media can erase scientific truths from public awareness.

The AstraZeneca vaccine is atleast 60% effective for people aged 70 and over

A study examining older people in the UK found that only one dose of the AstraZeneca vaccine is atleast 60% effective for people aged 70 and over.

Scientists find that elevated neutrophils can predict severe COVID and death

Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.

Israel will now vaccinate Palestinians who have permits to work 

Israel faced international criticism on their refusal to vaccine Palestinians - now, the country will begin rolling out Pfizer shots to some Palestinians who have work permits.

The window for convalescent plasma donation is just under two months

New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.

The Pfizer vaccine is stopping 92% of severe COVID cases in Israel

Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.

REACT study: UK vaccine hesitancy is the highest in London

New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.

Data storage anxiety could delay the UK government’s digital ambitions

Steve Rafferty, UK and Ireland Manager, RingCentral, explains how leaders in government organisations can help to ease data storage anxiety through education.

Hong Kong approves the Sinovac COVID vaccine for use

The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders